![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
LJ Ignarro, RG Harbison, KS Wood and PJ Kadowitz
The objective of this study was to ascertain whether "endothelium- derived relaxing factor" (EDRF) released from bovine intrapulmonary artery and vein is capable of directly activating soluble guanylate cyclase, thereby accounting for elevated vascular levels of cyclic GMP during EDRF release. Isolated arterial and venous rings, after equilibration and depolarization in bath chambers, were transferred to reaction tubes and incubated with soluble guanylate cyclase that had been purified to homogeneity from bovine lung. Addition of test agents to either bath chambers or enzyme reaction mixtures enabled the determination of their sites of action. Arterial and venous rings caused an endothelium-dependent 2- to 3-fold enzyme activation that was inhibited by methylene blue. Endothelium-dependent enzyme activation in artery but not vein was enhanced several-fold by acetylcholine in an atropine-sensitive manner. Bradykinin, which relaxes both artery and vein when endothelium is intact, activated guanylate cyclase upon addition of endothelium-intact rings to enzyme reaction mixtures. Vasoactive intestinal peptide, which causes endothelium-dependent relaxation of artery but not vein, also activated guanylate cyclase in the presence of endothelium-intact artery but not vein. Arachidonic acid activated the enzyme directly as well as through EDRF release from artery but not vein. Atrial peptides, prostacyclin, isoproterenol and nitroglycerin were inactive. Methylene blue was a powerful inhibitor of EDRF-elicited activation of guanylate cyclase but was without effect when rings were merely pretreated with methylene blue in bath chambers with no further addition to enzyme reaction mixtures. Thus, methylene blue did not interfere with the formation, release or chemical stability of EDRF, but rather inhibited its influence on guanylate cyclase. No agent was found to inhibit EDRF generation or release.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  A.-C. Peyter, V. Muehlethaler, L. Liaudet, M. Marino, S. Di Bernardo, G. Diaceri, and J.-F. Tolsa Muscarinic receptor M1 and phosphodiesterase 1 are key determinants in pulmonary vascular dysfunction following perinatal hypoxia in mice Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L201 - L213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gkaliagkousi, J. Ritter, and A. Ferro Platelet-Derived Nitric Oxide Signaling and Regulation Circ. Res., September 28, 2007; 101(7): 654 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Burgoyne, M. Madhani, F. Cuello, R. L. Charles, J. P. Brennan, E. Schroder, D. D. Browning, and P. Eaton Cysteine Redox Sensor in PKGIa Enables Oxidant-Induced Activation Science, September 7, 2007; 317(5843): 1393 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Weiss, N. Ide, T. Abahji, L. Nill, C. Keller, and U. Hoffmann Aged Garlic Extract Improves Homocysteine-Induced Endothelial Dysfunction in Macro- and Microcirculation J. Nutr., March 1, 2006; 136(3): 750S - 754S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Oishi, A. Grobe, E. Benavidez, B. Ovadia, C. Harmon, G. A. Ross, K. Hendricks-Munoz, J. Xu, S. M. Black, and J. R. Fineman Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension: a role for superoxide and peroxynitrite in the intact lamb Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L359 - L366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Koenigsberger, R. Sauser, J.-L. Beny, and J.-J. Meister Role of the Endothelium on Arterial Vasomotion Biophys. J., June 1, 2005; 88(6): 3845 - 3854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. B. Campbell, N. Spitzbarth, K. M. Gauthier, and S. L. Pfister 11,12,15-Trihydroxyeicosatrienoic acid mediates ACh-induced relaxations in rabbit aorta Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2648 - H2656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ovadia, O. Reinhartz, R. Fitzgerald, J. M. Bekker, M. J. Johengen, A. Azakie, S. Thelitz, S. M. Black, and J. R. Fineman Alterations in ET-1, not nitric oxide, in 1-week-old lambs with increased pulmonary blood flow Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H480 - H490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Stuart-Smith Demystified ... Nitric oxide Mol. Pathol., December 1, 2002; 55(6): 360 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia Vascular Medicine, August 1, 2002; 7(3): 227 - 239. [Abstract] [PDF]
|
|
|
|
 |
|
 S. D. Koh, K. Monaghan, G. P. Sergeant, S. Ro, R. L. Walker, K. M. Sanders, and B. Horowitz TREK-1 Regulation by Nitric Oxide and cGMP-dependent Protein Kinase. AN ESSENTIAL ROLE IN SMOOTH MUSCLE INHIBITORY NEUROTRANSMISSION J. Biol. Chem., November 16, 2001; 276(47): 44338 - 44346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Cooke, B. M. Wall, K. M. Huch, and T. Mangold Cardiovascular effects of vasopressin following V1 receptor blockade compared to effects of nitroglycerin Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R887 - R893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Sprague, A. H. Stephenson, M. L. Ellsworth, C. Keller, and A. J. Lonigro Impaired Release of ATP from Red Blood Cells of Humans with Primary Pulmonary Hypertension Experimental Biology and Medicine, May 1, 2001; 226(5): 434 - 439. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. Cummings and H. Wang Nitric oxide decreases lung liquid production via guanosine 3',5'-cyclic monophosphate Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L923 - L929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. Kwon, H. Ozaki, and H. Karaki NO donor sodium nitroprusside inhibits excitation-contraction coupling in guinea pig taenia coli Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1235 - G1241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Kramp, P. Fourmanoir, L. Ladriere, E. Joly, C. Gerbaux, A. el Hajjam, and N. Caron Effects of Ca2+ channel activity on renal hemodynamics during acute attenuation of NO synthesis in the rat Am J Physiol Renal Physiol, April 1, 2000; 278(4): F561 - F569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Tworetzky, P. Moore, J. M. Bekker, J. Bristow, S. M. Black, and J. R. Fineman Pulmonary blood flow alters nitric oxide production in patients undergoing device closure of atrial septal defects J. Am. Coll. Cardiol., February 1, 2000; 35(2): 463 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Black, R. S. Heidersbach, D. M. McMullan, J. M. Bekker, M. J. Johengen, and J. R. Fineman Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1849 - H1856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Black, J. R. Fineman, R. H. Steinhorn, J. Bristow, and S. J. Soifer Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1643 - H1651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yamashita, R. A. Schmid, K. Ando, J. D. Cooper, and G. A. Patterson Nitroprusside Ameliorates Lung Allograft Reperfusion Injury Ann. Thorac. Surg., September 1, 1996; 62(3): 791 - 796. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. F. Pratt, M. Rosolowsky, and W. B. Campbell Mediators of Arachidonic Acid–Induced Relaxation of Bovine Coronary Artery Hypertension, July 1, 1996; 28(1): 76 - 82. [Abstract] [Full Text]
|
|
|
|
|
|
O. Zolle, A. M. Lawrie, and A. W. M. Simpson Activation of the Particulate and Not the Soluble Guanylate Cyclase Leads to the Inhibition of Ca2+ Extrusion through Localized Elevation of cGMP J. Biol. Chem., August 18, 2000; 275(34): 25892 - 25899. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
